Target |
Mechanism IKKε inhibitors [+1] |
Active Org. |
Originator Org. |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. JP |
First Approval Date01 Jan 1987 |
Mechanism IKKε inhibitors [+3] |
Active Org.- |
Originator Org. |
Active Indication- |
Inactive Indication |
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Target |
Mechanism IKKε inhibitors [+2] |
Active Org.- |
Originator Org. |
Active Indication- |
Inactive Indication |
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date05 Oct 2019 |
Sponsor / Collaborator |
Start Date01 Jan 2014 |
Sponsor / Collaborator |
Start Date19 Jul 2013 |
Sponsor / Collaborator |